Early efficacy of first Pfizer COVID-19 shot in new study doesn't disprove Canada's dosing strategy: author

The author of a new study that cast doubt on the early efficacy of the Pfizer-BioNech coronavirus vaccine against variants of concern says he believes the data is not applicable to the situation in Canada where doses are being spaced out by up to four months.